Relmada Therapeutics has acquired complete worldwide ownership rights to Sepranolone from Sweden-based Asarina Pharma.

A rookie-listed Port Adelaide player is giving his journey with Tourette’s syndrome a new platform to inspire others.

Relmada, which has turned to strategic options after scrapping two phase 3 trials in major depressive disorder (MDD), is ...

There's a big stigma surrounding Tourette syndrome and other brain disorders, but Milan teacher Larry Biederman is working to break ...

The next episode of “Baylen Out Loud” tonight is called “Going For Narnia!” “Baylen Out Loud” airs at 9 p.m. Monday, Feb. 3, ...

In PEOPLE's exclusive sneak peek at an upcoming episode of TLC's 'Baylen Out Loud', Baylen Dupree decides to try Botox for ...

Baylen Out Loud star Baylen Dupree is taking a major step with boyfriend Colin Dooley. The 22-year-old influencer was ...

Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from ...

Tourette syndrome is currently diagnosed about three times more frequently in males than in females. A new study finds that female individuals are less likely to be diagnosed with the syndrome, take ...

Low-quality information on social media may be contributing to a rise in teen mental illness. A new construct may help ...